Cargando…

Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study

Despite being clinically underestimated, sexual dysfunction (SD) is one of the most frequent and lasting adverse effects associated with antidepressants. Desvenlafaxine is an antidepressant (AD) with noradrenergic and serotonergic action that can cause a lower SD than other serotonergic ADs although...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montejo, Angel L., Becker, Joemir, Bueno, Gloria, Fernández-Ovejero, Raquel, Gallego, María T., González, Nerea, Juanes, Adrián, Montejo, Laura, Pérez-Urdániz, Antonio, Prieto, Nieves, Villegas, José L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571783/ https://www.ncbi.nlm.nih.gov/pubmed/31117203 http://dx.doi.org/10.3390/jcm8050719

Ejemplares similares

Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach
por: Montejo, Angel L., et al.
Publicado: (2019)

Frequency of Iatrogenic Sexual Dysfunction Associated with Antihypertensive Compounds
por: Buch-Vicente, Bárbara, et al.
Publicado: (2021)

Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
por: Montejo, Angel L., et al.
Publicado: (2021)

Desvenlafaxine
por: Andrade, Chittaranjan
Publicado: (2009)

New Challenges in Sexuality and Sexual Dysfunction
por: Montejo, Angel L.
Publicado: (2022)

Understanding the Mechanism of Antidepressant-Related Sexual Dysfunction: Inhibition of Tyrosine Hydroxylase in Dopaminergic Neurons after Treatment with Paroxetine but Not with Agomelatine in Male Rats
por: Santana, Yanira, et al.
Publicado: (2019)

Desvenlafaxine in the treatment of major depressive disorder
por: Lourenco, Maria Teresa C, et al.
Publicado: (2009)

Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment
por: Llanes, Carlos, et al.
Publicado: (2019)

Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review
por: Casado-Espada, Nerea M., et al.
Publicado: (2019)

Sexuality and Mental Health: The Need for Mutual Development and Research
por: Montejo, Angel L.
Publicado: (2019)

Venlafaxine and desvenlafaxine in the management of menopausal hot flashes
por: Johnson, Emily D, et al.
Publicado: (2011)

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin
por: Aguilar, Lourdes, et al.
Publicado: (2019)

Desvenlafaxine-associated hyperglycemia: A case report and literature review
por: Mekonnen, Andrea D., et al.
Publicado: (2020)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
por: Umland, Elena M, et al.
Publicado: (2012)

Drug–drug interactions involving antidepressants: focus on desvenlafaxine
por: Low, Yvette, et al.
Publicado: (2018)

Desvenlafaxine-Induced Interstitial Pneumonitis: A Case Report
por: Flora, Arjan, et al.
Publicado: (2018)

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
por: Atkinson, Sarah, et al.
Publicado: (2018)

Prenatal desvenlafaxine induced behavioural alterations in Swiss albino mice
por: Kumari, Amrita, et al.
Publicado: (2014)

Categorical improvement in functional impairment in depressed patients treated with desvenlafaxine
por: Soares, Claudio N., et al.
Publicado: (2019)

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023)

Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy
por: Allen, Rob, et al.
Publicado: (2014)

LC–UV and LC–MS evaluation of stress degradation behavior of desvenlafaxine
por: Pawar, Shubhangi M., et al.
Publicado: (2012)

Periodontal status in chronic periodontitis depressed patients on desvenlafaxine: An observational study
por: Bhatia, Anu, et al.
Publicado: (2018)

Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets
por: Samy, Wael, et al.
Publicado: (2017)

Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery
por: Tong, Gui-Feng, et al.
Publicado: (2017)

A Comparative Study on Safety and Efficacy of Desvenlafaxine Versus Sertraline in Depression
por: Ch, Saritha, et al.
Publicado: (2022)

Desvenlafaxine Extended-Release in Panic Disorder: A Retrospective Chart Review
por: Min Lee, Sang, et al.
Publicado: (2022)

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy
por: Lieberman, Daniel Z, et al.
Publicado: (2010)

Desvenlafaxine May Accelerate Neuronal Maturation in the Dentate Gyri of Adult Male Rats
por: Asokan, Aditya, et al.
Publicado: (2014)

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder
por: Katzman, Martin A., et al.
Publicado: (2017)

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder
por: Weihs, Karen L., et al.
Publicado: (2018)

Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting
por: Lee, Kyoung-Uk, et al.
Publicado: (2010)

Consensus on Recommendations for Safe Sexual Activity during the COVID-19 Coronavirus Pandemic
por: Cabello, Francisco, et al.
Publicado: (2020)

PS210. Effect of Desvenlafaxine on Altered Heart Rate Variability in Persistent Depressive Disorder
por: Ravindran, Arun V., et al.
Publicado: (2016)

Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials: Toward Personalized Treatment for Depression
por: Zilcha-Mano, Sigal, et al.
Publicado: (2021)

Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine
por: Benoit, James R.A., et al.
Publicado: (2021)

Desvenlafaxine Overdose-induced Toxic Cardiomyopathy and Acute Left Ventricular Failure: A Case Report
por: Goyal, Sandeep Kumar, et al.
Publicado: (2018)

PS100. Open-label Desvenlafaxine as Monotherapy for Persistent Depression Disorder: A Pilot Study
por: Ravindran, Arun V., et al.
Publicado: (2016)

Single-step extraction for simultaneous quantification of desvenlafaxine and alprazolam in human spiked plasma by RP-HPLC
por: Rao, Huma, et al.
Publicado: (2020)

Desvenlafaxine As the Main Possible Culprit in Triggering Reversible Cerebral Vasoconstriction Syndrome: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q28sij3u46igd98jssf6a5h038